Q1 2014

Source filing unavailable

Q1 2014 · —

Revenue

$17.88M

no prior Q1 2013 on file

Net Income

-$16.24M

no prior Q1 2013 on file

EPS Diluted

-$1.23

no prior Q1 2013 on file

Operating Income-$14,206,000—

Operating Cash Flow-$15,521,000—

Free Cash Flowderived

Same quarter

no prior Q1 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR